Claritas Rx
South San Francisco, US · Founded 2021 · Delaware corporation · 136 employees on LinkedIn · 1 known investors
Find your way into Claritas Rx
1,138 people in our graph share verified history with the Claritas Rx team — schools, employers, funds. One of them is your warm intro.
Adrianna Maunlockedknows Mike Fitzgibbons · together at Morgan Stanley (overlapped)
×4knows the team · via Morgan Stanley
×2knows the team · via University of California, Berkeley
×2knows the team · via Case Western Reserve University
knows the team · via Milton Academy
×2knows the team · via Amherst College
Claritas Rx provides AI-powered patient journey analytics and care coordination software for specialty and rare disease pharmaceutical brands, helping identify and remove barriers to patient treatment access and adherence. The platform integrates de-identified pharmacy data with care coordination tools to help healthcare teams optimize medication adherence and reduce treatment abandonment.
Founders & leadership
SK
Stuart KamininSVP, Analytics & InnovationSVP of Analytics & Innovation at Claritas Rx, a software platform providing AI-powered patient journey analytics and care coordination for specialty pharmaceutical brands. Kamin brings expertise in health information technology, health system design, and commercial strategy in the life sciences sector.
MF
Mike FitzgibbonsinCEOBefore founding the company in 2011, he spent six years at Genentech, where he served as Group Manager of Pricing Strategy and later as Group Product Manager on the Avastin marketing team. He began his career as a research analyst at Morgan Stanley, a role he held for seven years.
BB
Bhupesh BajajinChief Technology OfficerBhupesh Bajaj is a healthcare technology executive with experience leading engineering and product teams at companies acquired by major firms. He has background in SaaS product development, distributed systems, machine learning operations, and cloud infrastructure, with expertise in healthcare compliance including HIPAA and HITECH standards.
MV
Manoshi VasudevanNamed on SEC filing
NK
Nicholas KrokoszynskiNamed on SEC filing
MB
Mauricio BuitragoNamed on SEC filing
Board
BS
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.1M disclosed across 4 rounds · 2017–2021
▶$13.6MraisedFeb 2021 · 9 investors · Other TechnologyRule 506(b)
▶$13.6MraisedFeb 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Manoshi VasudevanExecutive Officer
- Nicholas KrokoszynskiExecutive Officer
- Bradley SloanDirector
- Stuart KaminExecutive Officer
- Mauricio BuitragoExecutive Officer
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $13.6M
- Amount sold
- $13.6M
- Minimum investment
- $25K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$997KraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$997KraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $997K
- Amount sold
- $997K
- Minimum investment
- $50K
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJul 2020 · 20 investors · Other TechnologyRule 506(b)
▶$2.9MraisedJul 2020 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- Minimum investment
- $25K
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$1.6MraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- First sale
- Jan 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Claritas Rx went on to found or lead other companies.
Competitors · 3
by search overlap
IQVIA53 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Syneos Health50 shared keywordsSyneos Health is a fully integrated biopharmaceutical solutions organization that provides clinical, medical affairs, and commercial services to help pharmaceutical companies accelerate market access and patient outcomes.
ConnectiveRx48 shared keywordsConnectiveRx provides hub services, patient support, and patient affordability programs that help pharmaceutical manufacturers, healthcare providers, and patients access and stay on prescribed therapies. It offers point-of-care awareness and adherence messaging as a single-partner solution for medication access in the pharmaceutical industry.
Companies competing with Claritas Rx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Claritas Rx do?
- Claritas Rx provides AI-powered patient journey analytics and care coordination software for specialty and rare disease pharmaceutical brands, helping identify and remove barriers to patient treatment access and adherence. The platform integrates de-identified pharmacy data with care coordination tools to help healthcare teams optimize medication adherence and reduce treatment abandonment.
- Who are Claritas Rx's investors?
- Claritas Rx's investors include Questa Capital.
- How much funding has Claritas Rx raised?
- Claritas Rx has disclosed $19.1M raised across 4 rounds.
- Where is Claritas Rx headquartered?
- Claritas Rx is headquartered in South San Francisco, US.